ouabain has been researched along with Graves Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Riva, C; Frigato, F; Virgili, F | 1 |
| Ajjan, RA; Crisp, M; Findlay, C; Ludgate, M; Metcalfe, RA; Watson, PF; Weetman, AP | 1 |
| De Riva, C; Vircici, F | 1 |
1 trial(s) available for ouabain and Graves Disease
| Article | Year |
|---|---|
Na+, K+ ATPase activity in red cells predicts the recurrence of hyperthyroidism in patients with Graves' disease.
Topics: Adult; Antithyroid Agents; Enzyme Inhibitors; Erythrocytes; Female; Graves Disease; Humans; Hyperthyroidism; Male; Methimazole; Ouabain; Prognosis; Receptors, Thyrotropin; Recurrence; Sodium-Potassium-Exchanging ATPase; Thyroid Function Tests | 1995 |
2 other study(ies) available for ouabain and Graves Disease
| Article | Year |
|---|---|
The modulation of the human sodium iodide symporter activity by Graves' disease sera.
Topics: Animals; Antibodies; Carrier Proteins; Case-Control Studies; CHO Cells; Cricetinae; Graves Disease; Humans; Iodides; Membrane Proteins; Ouabain; Perchlorates; Recombinant Proteins; Sodium Compounds; Symporters; Thiocyanates; Transfection | 1998 |
Impaired Na+,K+ATPase activity in red blood cells in euthyroid women treated with levothyroxine after total thyroidectomy for Graves' disease.
Topics: Adult; Binding Sites; Erythrocytes; Female; Graves Disease; Hormone Replacement Therapy; Humans; Ouabain; Sodium-Potassium-Exchanging ATPase; Thyroidectomy; Thyroxine | 1998 |